Skip to content
Home/Companies/Biotech/Bactolife

Bactolife

Biotech·Denmark·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Bactolife?

Bactolife is a Danish Biotech company, currently owned by Eifo since 2026 and Novo Holdings.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Most recent investor
Novo Holdings
Novo Holdings Bioindustrial Investments · 1999 · Buyout
2 ownership periods · full history below

Key facts

HQDenmark
SectorBiotech
StatusActive

Ownership history

2 ownership periods

Active
Co-held by Novo Holdings and Eifo since 2021.
Novo Holdings
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Bioindustrial Investments · 1999 · Buyout
Eifo
EifoActive
2026 · present(<1yr) · EIFO (direct equity) · 1992 · VC

More from Novo Holdings Bioindustrial Investments

Other portfolio companies in the same fund.

Elo Life Systems
Active
AgTechUS· 2022
21st.BIO
Active
BiotechDenmark· 2021
AMSilk
Active
BiotechGermany· 2021
Esco Aster
Active
FoodTechSingapore· 2021
Geno
Active
BiotechUS· 2021
Zencore Biologics
Active
BiotechUS· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Bactolife?

Bactolife is currently owned by Eifo and Novo Holdings, through Novo Holdings Bioindustrial Investments, since 2026.

When did Eifo and 1 other acquire Bactolife?

Eifo and 1 other acquired Bactolife in 2026.

Who has owned Bactolife over time?

Bactolife has been through 2 private-equity ownership periods: Novo Holdings · via Novo Holdings Bioindustrial Investments · since 2021; Eifo · via EIFO (direct equity) · since 2026.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue